Synthetic Growth Hormone-Releasing Hormone Agonist Ameliorates the Myocardial Pathophysiology Characteristic of HFpEF

Researchers demonstrated that the activation of the growth hormone-releasing hormone receptor signaling pathway within the myocardium both prevented and reversed diastolic dysfunction and pathophysiologic features consistent with heart failure with preserved ejection fraction (HFpEF).
[Cardiovascular Research]
AbstractGraphical Abstract

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News